MedTrace Logo

Morbid Rates After Spiriva Chronic Obstructive Pulmonary Disease (COPD) Protocol Change

NCT06053541 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3015000

Last updated 2024-10-26

Study results available
· View outcomes & findings →

Summary

This study evaluates hospitalizations and mortality in patients with Chronic Obstructive Pulmonary Disease (COPD) before and after the implantation of a new COPD treatment plan (replacement of tiotropium soft mist inhaler for glycopyrronium dry powder inhaler) by the Health State Secretariat of Federal District in Brazil.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Sponsors & Collaborators

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-07-01
Completion
2021-07-01

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06053541 on ClinicalTrials.gov